Back
ESC Premium Access

Clopidogrel use as single antiplatelet therapy in outpatients with stable coronary artery disease: prevalence, correlates and association with prognosis (from the CORONOR study)

Session: Poster session 6 - Antiplatelet therapy
Topic: Thrombosis and platelets
Speaker: Professor G. Lemesle (Lille, FR)
Event: ESC Congress 2016

Congress Presentation

Add to my library

Like

About the speaker

Professor Gilles Lemesle

Lille University Hospital, Lille (France)
1 presentation
0 follower

22 more presentations in this session

Comparison of the new oral P2Y12 inhibitor (Prasugrel/Ticagrelor) to Clopidogrel in type 2 diabetes mellitus patients with AMI

Speaker: Doctor M. Kim (Daejeon, KR)

Access
Abstract
Like
Thumbnail

Impact of antiplatelet drugs on cholesterol level of platelet lipid rafts

Speaker: Mrs V. Rabani (Besancon, FR)

Access
Abstract
Slides
Like
Thumbnail

Optical coherence tomography assessment of in-stent thrombus immediately after percutaneous coronary intervention in patients pretreatment with Prasugrel compared to Clopidogre

Speaker: Doctor Y. Katayama (Wakayama, JP)

Access
Abstract
Slides
Like
Thumbnail

Circadian variation of platelets inhibition with ticagrelor

Speaker: Doctor S. Fournier (Lausanne, CH)

Access
Abstract
Slides
Like
Thumbnail

Platelet reactivity is gender and age related

Speaker: Mr G. Vos (Nieuwegein, NL)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster session 6 - Antiplatelet therapy

Speakers: Professor G. Lemesle, Doctor M. Kim, Mrs V. Rabani, Doctor Y. Katayama, Doctor S. Fournier...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources